País: Nova Zelândia
Língua: inglês
Origem: Medsafe (Medicines Safety Authority)
Perflutren 1.1 mg/mL
Global Medical Solutions (NZ) Limited
Perflutren 1.1 mg/mL
1.1 mg/mL
Solution for injection
Active: Perflutren 1.1 mg/mL Excipient: Colfosceril palmitate Dibasic sodium phosphate monohydrate Glycerol Sodium dipalmitoylphosphatidate N-(Methoxy-PEG-5000 carbamoyl)-dipalmitoylphosphatidylethanolamine sodium Monobasic sodium phosphate monohydrate Propylene glycol Sodium chloride Water for injection
Vial, glass, clear, 4 dose units
General sale
General sale
Fluoromed LP
Package - Contents - Shelf Life: Vial, glass, clear - 4 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)
2007-05-31
NEW ZEALAND DATA SHEET _New Zealand Data Sheet - 30_ _ _ _June 2019 _ _ _ _Page 1 of 10 _ 1 PRODUCT NAME DEFINITY® (perflutren lipid microsphere) dispersion for injection. Octafluoropropane and perfluoropropane are synonyms for perflutren. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The perflutren lipid microspheres are composed of perflutren encapsulated in an outer lipid shell consisting of (R) - hexadecanoic acid, 1 –[(phosphonoxy)methyl]-1,2-ethanediyl ester, monosodium salt (abbreviated DPPA); (R) - 4-hydroxy-N,N,N-trimethyl-l0-oxo-7-[(l-oxohexadecyl)oxy]-3,4,9-trioxa-4-phosphapentacosan-l- aminium, 4-oxide, inner salt (abbreviated DPPC); and (R) ά-[6-hydroxy-6-oxido-9-[(1- oxohexadecyl)oxy]5,7,11-trioxa-2-aza-6-phosphahexacos-1-yl]-ω-methoxypoly(ox-l,2-ethanediyl), monosodium salt (abbreviated MPEG5000 DPPE). The CAS number of DEFINITY ® is [76-19-7]. The physical and chemical characteristics of perflutren gas are provided in Table 1. Table 1 Physical and Chemical Characteristics of Perflutren Physical/Chemical Property Characteristic Appearance Colorless gas Boiling point (1 atmosphere) -36.7°C Freezing Point (1 atmosphere) -183°C Density, Liquid (20°C) 1.350 g/mL Perflutren is chemically characterized as 1,1,1,2,2,3,3,3-octafluoropropane. It has a molecular weight of 188, empirical formula of C 3 F 8 and has the following structural formula: Prior to Vialmix TM activation, the DEFINITY ® vial contains 6.52_ _mg/mL perflutren in the headspace. Each mL of the clear liquid contains 0.75 mg lipid blend (consisting of 0.045 mg DPPA, 0.401 mg DPPC, and 0.304 mg MPEG5000 DPPE), 103.5 mg propylene glycol, 126.2 mg glycerin, 2.34 mg sodium phosphate monobasic monohydrate, 2.16 mg sodium phosphate dibasic heptahydrate, and 4.87 mg sodium chloride in Water for Injection. The pH is 6.2-6.8. F F F F F F F F NEW ZEALAND DATA SHEET _New Zealand Data Sheet - 30_ _ _ _June 2019 _ _ _ _Page 2 of 10 _ After activating the contents of the vial in a Vialmix TM , each mL of the milky white suspension contains a maximu Leia o documento completo